Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
After finishing at $0.31 in the prior trading day, Co-Diagnostics Inc (NASDAQ: CODX) closed at $0.32, up 3.91%. In other words, the price has increased by $3.91 from its previous closing price. On the day, 1.25 million shares were traded. CODX stock price reached its highest trading level at $0.335 during the session, while it also had its lowest trading level at $0.2951.
Ratios:
Our goal is to gain a better understanding of CODX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.83 and its Current Ratio is at 4.12. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.02.
On December 29, 2021, Sidoti started tracking the stock assigning a Buy rating and target price of $14.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CODX now has a Market Capitalization of 11538599 and an Enterprise Value of 626067. For the stock, the TTM Price-to-Sale (P/S) ratio is 21.55 while its Price-to-Book (P/B) ratio in mrq is 0.28. Its current Enterprise Value per Revenue stands at 0.624 whereas that against EBITDA is -0.017.
Stock Price History:
The Beta on a monthly basis for CODX is 0.76, which has changed by -0.79810125 over the last 52 weeks, in comparison to a change of 0.1513431 over the same period for the S&P500. Over the past 52 weeks, CODX has reached a high of $2.23, while it has fallen to a 52-week low of $0.23. The 50-Day Moving Average of the stock is 17.15%, while the 200-Day Moving Average is calculated to be -39.37%.
Shares Statistics:
The stock has traded on average 2.28M shares per day over the past 3-months and 10026680 shares per day over the last 10 days, according to various share statistics. A total of 36.18M shares are outstanding, with a floating share count of 35.06M. Insiders hold about 9.00% of the company’s shares, while institutions hold 13.48% stake in the company. Shares short for CODX as of 1753920000 were 596954 with a Short Ratio of 0.26, compared to 1751241600 on 283384. Therefore, it implies a Short% of Shares Outstanding of 596954 and a Short% of Float of 1.9199998999999999.
Earnings Estimates
The stock of Co-Diagnostics Inc (CODX) is currently being evaluated by 2.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is -$0.12, with high estimates of -$0.09 and low estimates of -$0.16.
Analysts are recommending an EPS of between -$0.67 and -$0.67 for the fiscal current year, implying an average EPS of -$0.67. EPS for the following year is -$0.44, with 2.0 analysts recommending between -$0.39 and -$0.5.
Revenue Estimates
A total of 2 analysts have provided revenue estimates for CODX’s current fiscal year. The highest revenue estimate was $813k, while the lowest revenue estimate was $213k, resulting in an average revenue estimate of $513k. In the same quarter a year ago, actual revenue was $3.92M
